Parathyroid carcinoma: Epidemiology and Genetics

Endocrine Oncology · Published 2026-07-29 · DOI 10.1530/eo-25-0104

Free full text

Authors (2)

Daniela Betea, Patrick Petrossians

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Betea, D., Petrossians, P. (2026). Parathyroid carcinoma: Epidemiology and Genetics. Endocrine Oncology. https://doi.org/10.1530/eo-25-0104

Related articles

• HbA1c screening in patients with early breast cancer receiving endocrine therapy · Endocrine Oncology · 2025 · Same journal
• Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas · Endocrine Oncology · 2025 · Same journal
• Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE · Endocrine Oncology · 2025 · Same journal
• 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence · Endocrine Oncology · 2025 · Same journal
• Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes · Endocrine Oncology · 2025 · Same journal
• To screen or not to screen: complexity of SDHA mutation management · Endocrine Oncology · 2026 · Same journal
• Adrenal crisis due to pembrolizumab-induced hypophysitis in a patient with triple-negative breast cancer · Endocrine Oncology · 2025 · Same journal
• Using routinely collected patient data to study the impact of type 2 diabetes on breast cancer · Endocrine Oncology · 2025 · Same journal
• Patient-reported symptom and urgent healthcare use in neuroendocrine tumors · Endocrine Oncology · 2026 · Same journal
• Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute · Endocrine Oncology · 2025 · Same journal